Skip to main content
PRIMR25SBER25 Main banner
Icon Legend
Presentation Icons
Human Subject Research - HSR
Human Subject Research - HSR
ACU/IACUC
ACU/IACUC
Institutional Leadership
Institutional Leadership
Crossover
Crossover
Live Streamed Session
Live Streamed Session
Live Session Recorded
Live Session Recorded
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Call for Session Proposal - CSP
Call for Session Proposal - CSP
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Evaluation

2025 SBER Conference

IRB Operations and Management

Social, Behavioral, and Educational Research

A03 - SBER and Biomedical IRBs: Opportunities for Shared Learning

Thursday, November 6, 2025
10:15 AM - 11:15 AM ET
Location: Room 318-320
Human Subject Research - HSR Learning Lab Series Call for Session Proposal - CSP
CLICK HERE to view captioning for this session! 

It is common for IRB offices to be structured around either SBER or biomedical research, whether due to the institution’s research portfolio or by intentional design. This division can help manage workload, focus expertise, and promote consistency in board review. However, this separation may also create knowledge gaps. This session, from the perspective of SBER-focused IRB staff, will explore what SBER and biomedical IRBs can learn from one another and how shared insights can strengthen review practices across domains.

Learning Objectives:

  • Review key differences in regulatory approaches, board expertise, and risk assessment between SBER and biomedical IRBs
  • Recognize areas where SBER IRB offices may benefit from support and insights from biomedical IRB counterparts
  • Explore collaborative strategies, including board consultations and shared educational initiatives